miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
Immune checkpoint inhibitors are a promising therapy for the treatment of cancers, including melanoma, that improved benefit clinical outcomes. However, a subset of melanoma patients do not respond or acquire resistance to immunotherapy, which limits their clinical applicability. Recent studies have...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ae1ff9ce822d4e288d12818cefbb94dc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|